Trial Profile
Lipiodol as an Imaging Biomarker of Tumor Necrosis After Transcatheter Chemoembolization Therapy in Patients With Primary and Metastatic Liver Cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Ethiodized oil (Primary)
- Indications Liver cancer
- Focus Biomarker; Therapeutic Use
- 28 May 2019 Planned End Date changed from 1 Mar 2019 to 1 Nov 2019.
- 28 May 2019 Planned primary completion date changed from 1 Nov 2018 to 1 Nov 2019.
- 26 Feb 2018 Planned End Date changed from 1 Oct 2017 to 1 Mar 2019.